VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AFGD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AFGDAmerican Financial Group, Inc.
$19.59$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAFGDQuarterly Financials

American Financial Group, Inc. (AFGD) Quarterly Financials

120+ quarters historyFree accessUpdated daily

American Financial Group, Inc. (AFGD) quarterly income statement — complete revenue, gross profit & net income history

AFGD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.85B2.06B2.27B1.86B1.79B2.14B2.29B1.81B1.88B1.99B2.07B1.75B1.65B1.91B1.92B1.49B1.55B1.72B1.66B1.46B
Revenue Growth %3.69%-3.51%-0.87%2.98%-4.94%7.55%10.63%3.49%14.35%4.19%7.7%17.23%6.2%11.06%15.5%2.47%5.37%5.92%7.22%3.78%
Medical Costs & Claims01.06B000000-25M0000-21M0000-90M-75M
Medical Cost Ratio %0%51.43%0%0%0%0%0%0%-1.33%0%0%0%0%-1.1%0%0%0%0%-5.41%-5.15%
Gross Profit01B2.27B1.86B1.79B2.08B2.29B1.81B1.91B1.99B2.07B1.75B1.65B1.93B1.92B1.49B1.55B1.72B1.75B1.53B
Gross Margin %0%48.57%100%100%100%97.38%100%100%101.33%100%100%100%100%101.1%100%100%100%100%105.41%105.15%
Gross Profit Growth %-100%-51.87%-0.87%2.98%-6.19%4.73%10.63%3.49%15.87%3.06%7.7%17.23%6.2%12.28%9.58%-2.55%5.37%5.92%-14.85%-21.53%
Operating Expenses0623M00041M00036M000150M1.69B0041M92M116M
OpEx / Revenue %0%30.2%0%0%0%1.92%0%0%0%1.81%0%0%0%7.86%88.09%0%0%2.39%5.53%7.97%
Depreciation & Amortization0000000020M000022M-229M00027M34M
Combined Ratio %0%81.63%0%0%0%1.92%0%0%-1.33%1.81%0%0%0%6.76%88.09%0%0%2.39%0.12%2.82%
Operating Income0379M259M1.86B1.79B3.58B2.29B1.81B3.58B1.95B2.07B1.75B1.65B392M229M1.49B1.55B1.68B291M307M
Operating Margin %0%18.37%11.41%100%100%167.49%100%100%190.11%98.19%100%100%100%20.55%11.91%100%100%97.61%17.49%21.09%
Operating Income Growth %-100%-89.42%-88.69%2.98%-50%83.45%10.63%3.49%117.39%397.96%803.93%17.23%6.2%-76.62%-21.31%385.99%5.37%6.48%64.41%88.34%
EBITDA0402M287M248M216M329M246M290M3.6B1.95B2.07B1.75B1.65B414M01.49B1.55B1.68B318M341M
EBITDA Margin %0%19.49%12.64%13.3%12.08%15.39%10.74%16.02%191.17%98.19%100%100%100%21.7%0%100%100%97.61%19.11%23.42%
Interest Expense23M23M19M19M19M19M19M19M19M19M19M19M19M20M19M23M0024M23M
Non-Operating Income0-23M-28M6M0-1M-6M-14M-25M1.95B2.07B1.75B1.65B26M01.49B1.55B1.68B17M-4M
Pretax Income239M379M268M229M197M320M229M271M304M335M219M255M264M346M210M206M361M445M267M288M
Pretax Margin %12.89%18.37%11.81%12.29%11.02%14.97%10%14.97%16.16%16.85%10.58%14.58%16.05%18.13%10.93%13.81%23.31%25.9%16.05%19.78%
Income Tax48M80M53M55M43M65M48M62M62M72M42M55M52M70M45M39M71M90M48M48M
Effective Tax Rate %20.08%21.11%19.78%24.02%21.83%20.31%20.96%22.88%20.39%21.49%19.18%21.57%19.7%20.23%21.43%18.93%19.67%20.22%17.98%16.67%
Net Income191M299M215M174M154M255M181M209M242M263M177M200M212M276M165M167M290M355M219M1B
Net Margin %10.3%14.49%9.47%9.33%8.61%11.93%7.9%11.55%12.87%13.23%8.55%11.44%12.89%14.47%8.58%11.19%18.72%20.66%13.16%68.82%
Net Income Growth %24.03%17.25%18.78%-16.75%-36.36%-3.04%2.26%4.5%14.15%-4.71%7.27%19.76%-26.9%-22.25%-24.66%-83.33%-30.79%-48.7%148.86%786.73%
EPS (Diluted)2.293.592.582.081.843.032.162.492.893.142.092.352.483.241.931.963.404.172.5711.71
EPS Growth %24.46%18.48%19.44%-16.47%-36.33%-3.5%3.35%5.96%16.53%-3.09%8.29%19.9%-27.06%-22.3%-24.9%-83.26%-29.75%37.17%159.6%829.37%
EPS (Basic)2.293.592.582.081.843.042.162.492.893.142.092.352.493.241.931.963.414.192.5811.79
Diluted Shares Outstanding83.3M83.4M83.4M83.5M83.8M84M83.9M83.9M83.8M83.8M84.7M85.2M85.4M85.3M85.4M85.3M85.2M85.2M85.2M85.6M